The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt

被引:25
|
作者
Wassef, Mona [1 ]
Abdelhaleim, Mona [1 ]
AbdulRahman, Eiman [1 ]
Ghaith, Doaa [1 ]
机构
[1] Cairo Univ, Fac Med, Dept Clin & Chem Pathol, Cairo 11559, Egypt
关键词
CARBAPENEM RESISTANCE;
D O I
10.1089/mdr.2014.0226
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: OmpK35 and OmpK36 are the major outer membrane porins of Klebsiella pneumoniae. We aimed to study the effect of combined porin loss and production of extended-spectrum -lactamases (ESBLs) on imipenem susceptibility among K. pneumoniae clinical isolates. Materials and Methods: This study included 91 suspected ESBL-producing K. pneumoniae clinical isolates, isolated from different patient specimens at the Cairo University hospital from January to June 2010. All isolates were subjected to genotypic analysis of the outer membrane protein gene expression using reverse transcription-PCR (RT-PCR) and analysis of OmpK35/36 of 38 isolates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Results: By RT-PCR, loss of Omp35 was detected in 78 (85.7%) isolates, loss of Omp36 was detected in 64 (70.32%), and loss of both porins was detected in 62 (68.1%). Out of 91 isolates, 45 (49.5%) were resistant to cefoxitin, and 17 (18.7%) were confirmed as derepressed AmpC producers. Omp35 was lost in all FOX-resistant isolates, whereas Omp36 was lost in 42 (93.3%) (p-value 0.002). The mean of ceftazidime inhibition zone diameter was significantly decreased among ESBL-producing isolates with loss of Omp35/36 (p-value 0.041 and 0.006), respectively. The mean of imipenem minimal inhibitory concentration (MIC) was markedly increased to 8.55g/ml among AmpC-producing isolates with Omp35/36 loss, while the mean of imipenem MIC among the 66 confirmed ESBL producers was 0.32g/ml. Conclusion: Imipenem MIC was markedly increased among K. pneumoniae isolates showing AmpC production with loss of both porins OmpK35/36. Meanwhile, the association of porin OmpK35/36 loss with ESBL production was not a direct cause of resistance to imipenem.
引用
收藏
页码:577 / 580
页数:4
相关论文
共 35 条
  • [31] Impact of ompk36 genotype and KPC subtype on the in vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producing K. pneumoniae clinical isolates
    Rogers, Tara M.
    Kline, Ellen G.
    Griffith, Marissa P.
    Jones, Chelsea E.
    Rubio, Abigail M.
    Squires, Kevin M.
    Shields, Ryan K.
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (02):
  • [32] High-Level Carbapenem Resistance among OXA-48-Producing Klebsiella pneumoniae with Functional OmpK36 Alterations: Maintenance of Ceftazidime/Avibactam Susceptibility
    Lumbreras-Iglesias, Pilar
    Rodicio, Maria Rosario
    Valledor, Pablo
    Suarez-Zarracina, Tomas
    Fernandez, Javier
    ANTIBIOTICS-BASEL, 2021, 10 (10):
  • [33] High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE
    Kaczmarek, Frank M.
    Dib-Hajj, Fadia
    Shang, Wenchi
    Gootz, Thomas D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) : 3396 - 3406
  • [34] Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss
    Lee, Kyungwon
    Yong, Dongeun
    Choi, Yeong Seon
    Yum, Jong Hwa
    Kim, June Myung
    Woodford, Neil
    Livermore, David M.
    Chong, Yunsop
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (02) : 201 - 206
  • [35] Prevalence, Antibiotic Susceptibility Pattern and Production of Extended-Spectrum β-Lactamases Amongst Clinical Isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia
    Ahmad, Shamweel
    Al-Juaid, Nami Fawazan
    Alenzi, Faris Q.
    Mattar, Essam H.
    Bakheet, Osama El-Sayed
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2009, 19 (04): : 264 - 265